ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome.

Sung Eun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.